Bradley Foster & Sargent’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
13,997
-11,975
-46% -$1.38M 0.02% 257
2026
Q1
$3.1M Buy
25,972
+419
+2% +$54.9K 0.05% 183
2025
Q4
$3.48M Buy
25,553
+3,018
+13% +$434K 0.05% 178
2025
Q3
$3.32M Buy
22,535
+2,069
+10% +$287K 0.05% 181
2025
Q2
$2.65M Buy
20,466
+17,599
+614% +$2.13M 0.04% 195
2025
Q1
$342K Sell
2,867
-45,328
-94% -$5.62M 0.01% 384
2024
Q4
$5.59M Sell
48,195
-33
-0.1% -$4.17K 0.09% 138
2024
Q3
$6.51M Buy
48,228
+345
+0.7% +$46.2K 0.11% 135
2024
Q2
$6.49M Buy
47,883
+351
+0.7% +$47.8K 0.12% 130
2024
Q1
$6.14M Buy
47,532
+391
+0.8% +$47.2K 0.11% 131
2023
Q4
$5.39M Buy
47,141
+1,957
+4% +$195K 0.1% 137
2023
Q3
$5.09M Hold
45,184
0.11% 138
2023
Q2
$5.09M Buy
+45,184
New +$4.78M 0.11% 138
2022
Q2
Sell
-2,595
Closed -$221K 474
2022
Q1
$221K Hold
2,595
﹤0.01% 446
2021
Q4
$311K Sell
2,595
-1,999
-44% -$248K 0.01% 385
2021
Q3
$568K Hold
4,594
0.01% 292
2021
Q2
$551K Buy
+4,594
New +$525K 0.01% 287

Other funds holding XYL

Bradley Foster & Sargent's XYL Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its Xylem (XYL) stake by 46% in Q2 2026, selling an estimated $1.38M and leaving 13,997 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #257.

Bradley Foster & Sargent first reported a position in XYL in Q2 2021 and has held it in 17 quarters since. The position peaked at $6.51M in Q3 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Bradley Foster & Sargent held 13,997 shares of Xylem worth $1.65M as of Q2 2026.
  • Bradley Foster & Sargent sold 11,975 Xylem shares in Q2 2026, an estimated $1.38M.
  • Xylem made up 0.02% of Bradley Foster & Sargent's portfolio in Q2 2026, its #257 holding.
  • Bradley Foster & Sargent first reported a position in Xylem in Q2 2021 and has held it in 17 quarters since.
  • Bradley Foster & Sargent's Xylem position peaked at $6.51M in Q3 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.